Trading Information Summary - On January 16, 2026, Rongtai Health (603579) closed at 26.63 yuan, down 3.9%, with a turnover rate of 5.93% and a trading volume of 120,500 shares, amounting to a transaction value of 324 million yuan [1] - On the same day, the net outflow of main funds was 49.9368 million yuan, accounting for 15.43% of the total transaction value [2] - Retail investors had a net inflow of 44.3469 million yuan, representing 13.7% of the total transaction value [1] Company Announcement Summary - Wanhe Securities conducted a site inspection for the 2025 continuous supervision of Rongtai Health from January 7 to 8, 2026 [1] - The inspection covered aspects such as corporate governance, internal control, information disclosure, use of raised funds, related party transactions, and operational status [1] - The results indicated that the company's governance structure is sound, information disclosure is compliant, and the use of raised funds is regulated, with no significant abnormal matters found [2]

Core Points - Shenzhen Breo Technology Co., Ltd. is established as a joint-stock company in accordance with relevant laws and regulations, with a registered capital of 85,945,419 RMB [1][2] - The company was approved for registration by the China Securities Regulatory Commission and listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 15, 2021, with an initial public offering of 15,410,000 shares [1][2] - The company's business scope includes the research and sale of health care equipment, electronic products, and various medical devices, among other activities [1][2] Company Structure - The company is governed by its articles of association, which outline the rights and obligations of shareholders, directors, and senior management [1][2] - The legal representative of the company is the director or general manager, who is responsible for the company's civil activities [1][2] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [1][2] Share Issuance and Management - The company's shares are issued in the form of stocks, with all shares being ordinary shares [2][3] - The total number of shares issued by the company is 85,945,419, and the issuance follows principles of openness, fairness, and justice [2][3] - The company can increase its capital through various methods, including issuing shares to unspecified objects or existing shareholders [2][3] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, participate in shareholder meetings, and supervise the company's operations [4][5] - Shareholders are obligated to comply with laws and the company's articles of association, and they cannot withdraw their capital except as permitted by law [8][9] - The company must maintain a shareholder register, which serves as proof of share ownership [4][5] Corporate Governance - The company is required to hold annual and temporary shareholder meetings, with specific procedures for convening and voting [10][11] - The board of directors is responsible for managing the company and must report to the shareholders at the annual meeting [10][11] - The articles of association stipulate that any external guarantees provided by the company must be approved by the shareholders [11][12] Compliance and Legal Obligations - The company must adhere to legal requirements regarding information disclosure and must report any significant events to the relevant authorities [6][7] - Shareholders have the right to request legal action against directors or senior management if they violate laws or the articles of association [6][7] - The company must ensure that its operations do not harm the interests of shareholders or creditors [8][9]